We will evaluate what the parties bring to us in terms of a negotiated resolution, but part of that evaluation.... If the assets are there and we think there's a viable operating business that will address the SLC, we move to looking at the buyer.
If the buyer itself raises competition concerns, that is one of the criteria we apply. We wouldn't approve a competitor's buying if we thought that was also going to lead to anti-competitive effects emanating from the remedy. Those are the things we look at with respect to the buyer.